Mrinal Patnaik
@mrinalpatnaik
Director Precision Genomics Clinic, Chronic Myelomonocytic Leukemia Epigenetics lab, Hematology, Mayo Clinic, Minnesota. 🇮🇳🇺🇸GSD and 🎾🏏fan for life!
ID: 1160009240918089731
10-08-2019 02:05:29
1,1K Tweet
3,3K Followers
602 Following
ASXL1/TET2 genotype-based risk stratification outperforms ASXL1 mutational impact and is independent of mutant variant allele fractions Clifford Csizmar Eric Padron MD Guillermo Montalban-Bravo Rami komrokji #CMML #TET2 #ASXL1TET2 Haematologica pubmed.ncbi.nlm.nih.gov/38899337/
Next up at #iwMPN24 Mrinal Patnaik (Mayo Clinic Comprehensive Cancer Center) talks on RASopathies, key features of RAS family-mutated chronic myelomonocytic leukemia and treatment options VJHemOnc #iwMDS24 #iwMPN24 #MPN #MPNsm #CMML
Hair follicle DNA extraction for germline testing in hematologic malignancies improves process efficiency, patient care and reduces costs, allowing for quicker treatment decision-making. Mayo Clinic hematologist-oncologist Dr. @mrinalpatnaik explains how: mayocl.in/45Mge6k
Hair follicle DNA extraction for germline testing in hematologic malignancies improves process efficiency, patient care and reduces costs, allowing for quicker treatment decision-making. Mayo Clinic hematologist-oncologist Dr. @mrinalpatnaik explains how: mayocl.in/3RZJMrI
Mayo Clinic Telomere Biology Disorders Group #Telomeres Team Telomere Mayo Clinic Center for Individualized Medicine Alex Ferrer Terra Lasho, PhD Doug Simonetto, MD Mayo Clinic Comprehensive Cancer Center Kristen McCullough MayoPCCM Dr Eva Carmina Dr Anna Zamora
Clonal Hematopoiesis in Patients With Neuroendocrine Tumor Treated With Lutetium-177 and the Risk of Thrombocytopenia … pubmed.ncbi.nlm.nih.gov/38976813/ yael kusne MD PhD Terra Lasho, PhD #Lutetium #CH #Radiotheranostics Mayo Clinic Comprehensive Cancer Center
How DNA guides cancer detection | Tomorrow's Cure Episode 3 youtu.be/x7CjqdQDSbg?si… via YouTube Mayo Clinic Comprehensive Cancer Center Kelly Bolton MD PhD #Cancergenomics
When you get an opportunity to write #CMML diagnostic criteria for the World Health Organization (WHO) with the dream team. Eric Padron MD Raphael Itzykson Joseph D. Khoury, MD, FCAP #Ericsolary Mayo Clinic Comprehensive Cancer Center Moffitt Cancer Center
Absence of PNH-clones in DDX41mutant-GPS aids in their distinction from acquired bone marrow failure syndromes ... sciencedirect.com/science/articl… yael kusne MD PhD Tim Chlon Talha Badar Mayo Clinic Comprehensive Cancer Center #DDX41 #Bonemarrowfailure
#MPNWorkshopNC | Mrinal Patnaik of Mayo Clinic is first up in the session on rare & overlap syndromes with his talk, 'Novel Therapeutic Targets in CMML'. This is sure to be an interesting session!👏 Atrium Health South Piedmont AHEC #MPNsm #HemOnc
Now online in Cancer Discovery: RNA shielding of p65 Is Required to Potentiate Oncogenic Inflammation in TET2-mutated #ClonalHematopoiesis - by Nana Adjoa Ben-Crentsil, Alexandre Gaspar Maia Mrinal Patnaik Eric Padron MD and colleagues doi.org/10.1158/2159-8… Mayo Clinic Moffitt Cancer Center
RNA shielding of P65 is required to potentiate oncogenic inflammation in TET2 mutated clonal hematopoiesis. pubmed.ncbi.nlm.nih.gov/39189614/ Our latest collaboration with Eric Padron MD Alexandre Gaspar Maia #TET2 #MALAT1 #CH Mayo Clinic Comprehensive Cancer Center Moffitt Cancer Center Cancer Discovery
Acute kidney injury, an underrecognized feature of VEXAS syndrome. pubmed.ncbi.nlm.nih.gov/39186250/ #VEXAS #Kidney Mayo Clinic Comprehensive Cancer Center KenWarringtonMD